HighVista Strategies LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.

Quarter-by-quarter ownership
HighVista Strategies LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q2 2022$612,000
-58.7%
12,108
-12.5%
0.37%
-68.8%
Q4 2021$1,483,000
+13.5%
13,843
+8.9%
1.18%
+36.5%
Q3 2021$1,307,000
+68.9%
12,716
+44.4%
0.86%
+57.6%
Q2 2021$774,000
+83.8%
8,805
+63.2%
0.55%
+57.3%
Q2 2020$421,0005,3960.35%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 716,539$36,192,00012.35%
CADIAN CAPITAL MANAGEMENT, LP 2,020,629$102,062,0006.89%
Casdin Capital, LLC 1,150,000$58,087,0004.91%
DAFNA Capital Management LLC 261,280$13,197,0003.60%
Nextech Invest Ltd. 188,228$9,507,0003.21%
Eagle Health Investments LP 170,551$8,615,0002.01%
Boxer Capital, LLC 507,374$25,627,0001.62%
Rock Springs Capital Management LP 979,174$49,458,0001.44%
EFG Asset Management (North America) Corp. 130,454$6,589,0001.39%
Integral Health Asset Management, LLC 130,000$6,566,0001.35%
View complete list of BLUEPRINT MEDICINES CORP shareholders